LESLIE BRITTON: Open Payments
NPI 1992350730 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 39 payments from 17 companies in 2025. Trend: 2023 $1,287 · 2024 $917 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $220 |
| ABBVIE INC. | 5 | $90 |
| Lilly USA, LLC | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 4 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Boston Scientific Corporation | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
Products named: AIRSUPRA, VRAYLAR, MOUNJARO, FARXIGA, VOQUEZNA, XIFAXAN, GEMTESA, EkoSonic.
Industry payments across AR — which companies pay providers there.
